Implementing Interpersonal Care Model for PPHTN Can Help Manage Blood Pressure Control
December 5th 2023A poster presented at ASHP Midyear 2023 highlighted the positive impact of including pharmacists in the care of postpartum women at risk of persistently elevated blood pressure (BP), particularly in cases of portopulmonary hypertension (PPHTN).
Chronic Insufficient Sleep Associated With Increased Insulin in Women
November 23rd 2023While data has associated insufficient sleep with increased risks of hypertension, cardiovascular disease, and disordered glucose metabolism, a potential source of insulin resistance and type 2 diabetes, much of this data was performed on male participants or evaluated short-term sleep restriction.
Women With Endometriosis More Likely to Experience Mental Health, Menstrual, Pain Symptoms
November 17th 2023Women with endometriosis face an average of 7 to 11 years between the time of symptom onset and diagnosis, during which they experience increased symptoms, hospitalizations, and health care resource utilization.
Misoprostol Alone Can be Effective Abortion Method
November 10th 2023The World Health Organization recommends either mifepristone in combination with misoprostol or misoprostol alone for abortion, but clinical evidence has indicated misoprostol alone has an effectiveness of 80% compared to 95% for mifepristone alongside misoprostol.
What Demographic Is The Most Likely To Receive Medication For Opioid Use Disorder?
May 8th 2023A new CDC report on data collected by the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy, indicates that medication for opioid use disorder is more often given to individuals who are White, older, and have private insurance.